Radioimmunotherapy with 90Y-Clivatizumab Tetraxetan plus Low Dose Gemcitabine versus Placebo plus Low-Dose Gemcitabine

Update Il y a 4 ans
Reference: EUCTR2013-004516-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Overall Survival (OS)


Inclusion criteria

  • Metastatic (Stage IV) Pancreatic Adenocarcinoma